Whales with a lot of money to spend have taken a noticeably bearish stance on Humana.

Looking at options history for Humana we detected 12 trades.

If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 66% with bearish.

From the overall spotted trades, 3 are puts, for a total amount of $320,328 and 9, calls, for a total amount of $309,620.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $450.0 for Humana over the recent three months.

Analyzing Volume & Open Interest

In terms of liquidity and interest, the mean open interest for Humana options trades today is 307.22 with a total volume of 1,870.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Humana's big money trades within a strike price range of $300.0 to $450.0 over the last 30 days.

Humana Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:

About Humana

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

In light of the recent options history for Humana, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is Humana Standing Right Now?

Currently trading with a volume of 771,898, the HUM's price is up by 1.52%, now at $340.69.

RSI readings suggest the stock is currently may be approaching overbought.

Anticipated earnings release is in 79 days.

What Analysts Are Saying About Humana

In the last month, 5 experts released ratings on this stock with an average target price of $358.0.

Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Humana, targeting a price of $381.

Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Humana, targeting a price of $370.

Maintaining their stance, an analyst from Cantor Fitzgerald continues to hold a Neutral rating for Humana, targeting a price of $360.

Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Humana, targeting a price of $326.

Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Humana, targeting a price of $353.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humana with Benzinga Pro for real-time alerts.